WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Trading Up 1.1% – Still a Buy?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY)’s share price shot up 1.1% during mid-day trading on Monday . The company traded as high as $8.19 and last traded at $8.19. 38,658 shares changed hands during trading, a decline of 10% from the average session volume of 43,130 shares. The stock had previously closed at $8.10.

Analyst Ratings Changes

Separately, UBS Group raised WuXi Biologics (Cayman) to a “buy” rating in a research report on Thursday, August 7th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of “Buy”.

WuXi Biologics (Cayman) Stock Down 1.1%

The firm’s 50 day simple moving average is $9.17 and its 200-day simple moving average is $8.11.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC.